Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
11/2002
11/28/2002CA2448186A1 Novel smg-1
11/28/2002CA2448185A1 Method for identifying micro-organisms using mass spectrometry
11/28/2002CA2448165A1 Pyruvate-kinase as a novel target molecule
11/28/2002CA2448153A1 Means and methods for identifying genes and proteins involved in the prevention and/or repair of a replication error
11/28/2002CA2448145A1 Engineered secreted alkaline phosphatase (seap) reporter genes and polypeptides
11/28/2002CA2448142A1 Beta-secretase substrates and uses thereof
11/28/2002CA2448125A1 Increasing bioavailability of carotenoids
11/28/2002CA2448102A1 Novel mixed lineage kinase (7) (mlk7) polypeptide, polynucleotides encoding the same, and methods of use thereof
11/28/2002CA2448092A1 Internalisation of virus into cells
11/28/2002CA2448018A1 Compositions and methods for inhibiting metastasis
11/28/2002CA2448014A1 Tsg101 as inhibitor of hiv production
11/28/2002CA2447958A1 Hypoxia inducible factors and uses thereof for inducing angiogenesis and improving muscular functions
11/28/2002CA2447823A1 Diagnosis of vascular disease susceptibility using bacteriophage phi-cpn1 host chlamydia
11/28/2002CA2447799A1 Emission ratiometric indicators of phosphorylation
11/28/2002CA2447680A1 Hevein-binding monoclonal antibodies
11/28/2002CA2447612A1 Selection of target sites for antisense attack of rna
11/28/2002CA2447357A1 Molecular toxicology modeling
11/28/2002CA2447340A1 Kinases and phosphatases
11/28/2002CA2447338A1 Receptors and membrane-associated proteins
11/28/2002CA2447336A1 Methods of detecting protein arginine methyltransferase, and uses related thereto
11/28/2002CA2447231A1 Methods for inhibiting angiogenesis
11/28/2002CA2447215A1 Adherent entities and uses therefor
11/28/2002CA2447161A1 Conjugates and compositions for cellular delivery
11/28/2002CA2447103A1 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
11/28/2002CA2443342A1 Mage-a3 peptides presented by hla class ii molecules
11/28/2002CA2441666A1 Phytases, nucleic acids encoding them and methods and using them
11/27/2002WO2001094575A1 Dna sequence regulating plant fruit-specific expression
11/27/2002EP1260817A2 Method for direct measurement of coagulation factor VIIa activity in plasma
11/27/2002EP1260816A1 Method of examining allergic diseases
11/27/2002EP1260597A2 Process for labeling a nucleic acid, including purification, and labeled RNA fragments obtained by this process
11/27/2002EP1260596A2 Process for labeling a ribonucleic acid, including optional signal amplification, and labeled RNA fragments which are obtained by this process
11/27/2002EP1260595A2 Nucleic acid-bondable magnetic carrier and method for isolating nucleic acid using the same
11/27/2002EP1260594A2 Arrangement of nucleic acid sequences and use thereof
11/27/2002EP1260593A2 Detection of nucleic acids by nuclease-catalyzed product formation
11/27/2002EP1260592A1 Biochip
11/27/2002EP1260591A1 High-efficiency assay for protein mannosyl transferases
11/27/2002EP1260590A1 Method of screening substance specifically inhibiting non-mevalonate pathway
11/27/2002EP1260589A2 Biosensor
11/27/2002EP1260587A2 Tyrosyl tRNA synthetase
11/27/2002EP1260583A1 System and method for manipulating magnetically responsive particles in fluid samples to collect DNA or RNA from a sample
11/27/2002EP1260519A1 Membrane receptors for steroids and sterols
11/27/2002EP1260228A2 Human growth gene and short stature gene region. Therapeutic uses
11/27/2002EP1259928A2 Process for estimating random error in chemical and biological assays
11/27/2002EP1259827A2 Biosynthetic carbohydrate-deficient transferrin references
11/27/2002EP1259824A1 Trisomy 21 cytotrophoblast cultures, and uses thereof for obtaining trisomy 21 markers
11/27/2002EP1259813A2 Diagnosis and treatment of malignant neoplasms
11/27/2002EP1259812A2 Breast, gastric and prostate cancer associated antigens and uses therefor
11/27/2002EP1259808A2 Method for labeling individual cells
11/27/2002EP1259800A2 Enzymatic-electrochemical measuring device
11/27/2002EP1259650A2 Estrogen receptor alpha variants and methods of detection thereof
11/27/2002EP1259649A2 Methods and composition for diagnosing and treating pseudoxanthoma elasticum and related conditions
11/27/2002EP1259648A2 Diagnostics and therapeutics for glaucoma
11/27/2002EP1259647A2 Methods for diagnosing, monitoring, staging, imaging and treating lung cancer via lung cancer specific genes
11/27/2002EP1259646A2 Pyrophosphorolysis activated polymerization (pap): application to allele-specific amplification and nucleic acid sequence determination
11/27/2002EP1259645A1 Universal variable fragments
11/27/2002EP1259644A2 Novel dna chips
11/27/2002EP1259643A2 Nucleic acid detection methods using universal priming
11/27/2002EP1259642A1 Nucleic acids, proteins, and antibodies
11/27/2002EP1259641A2 Combinatorial oligonucleotide pcr: a method for rapid, global expression analysis
11/27/2002EP1259640A2 Methods and compositions for the screening of cell cycle modulators
11/27/2002EP1259639A2 Essential gene and gene products for identifying, developing and optimising immunological and pharmacological active ingredients for the treatment of microbial infections
11/27/2002EP1259638A2 Methods for selectively modulating survivin apoptosis pathways
11/27/2002EP1259637A2 Caspase-inhibitory-factor (cif) and uses thereof
11/27/2002EP1259636A2 Method for determining the modulation of nad(p)h oxidoreductase
11/27/2002EP1259635A1 Methods of screening for antimicrobial compounds
11/27/2002EP1259634A2 Ex vivo generation of functional leukemia cells in a three-dimensional bioreactor
11/27/2002EP1259627A2 Heterologous expression of neisserial proteins
11/27/2002EP1259623A2 Aspartate carbamyltransferase as herbicidal target
11/27/2002EP1259621A2 Lipid metabolism enzymes
11/27/2002EP1259618A2 Human enzyme molecules
11/27/2002EP1259614A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/27/2002EP1259612A2 G-protein coupled receptor related polypeptides
11/27/2002EP1259611A2 G-protein coupled receptors
11/27/2002EP1259609A2 Human schizophrenia gene
11/27/2002EP1259606A2 Compositions useful for regulating parkin gene activity
11/27/2002EP1259604A1 Bcmp 84, a protein associated to breast cancer
11/27/2002EP1259603A2 Antisense oligonucleotides of the human chk1 gene and uses thereof
11/27/2002EP1259602A1 Methods of identifying synthetic transcriptional and translational regulatory elements, and compositions relating to same
11/27/2002EP1259599A1 Cell fusion assays using fluorescence resonance energy transfer
11/27/2002EP1259597A2 Zinc finger domains and methods of identifying same
11/27/2002EP1259595A2 Integrin antagonists
11/27/2002EP1259546A1 Ccr2-64i, polymorphic variant of the human ccr2 receptor and its use in the diagnostic and treatment of atherosclerosis
11/27/2002EP1259542A2 Reagents and methods useful for detecting diseases of the breast
11/27/2002EP1259540A1 Nucleic acids, proteins, and antibodies
11/27/2002EP1259531A2 Nucleic acids, proteins, and antibodies
11/27/2002EP1259530A1 Melanoma differentiation associated gene - 5 and promoter and uses thereof
11/27/2002EP1259529A2 Thermophilic dna polymerases from thermoactinomyces vulgaris
11/27/2002EP1259528A1 Nucleic acids, proteins and antibodies
11/27/2002EP1259527A1 35 human secreted proteins
11/27/2002EP1259526A2 Nucleic acids, proteins, and antibodies
11/27/2002EP1259525A1 Serine/threonine phosphatase polynucleotides, polypeptides, and antibodies
11/27/2002EP1259524A2 Nucleotides and polynucleotides immobilised on a solid support via a disulphide linkage
11/27/2002EP1259324A2 Multiple-site reaction device and method
11/27/2002EP1259258A1 Gm-negative ehv-mutants
11/27/2002EP1259255A1 Pai-2 conjugates for the treatment and imaging of cancer
11/27/2002EP1259249A1 Method for detecting the presence of target bacteria or a target component carbohydrate antigen thereof
11/27/2002EP1259248A1 Methods for treating, screening for, and detecting cancers expressing vascular endothelial growth factor d
11/27/2002EP1259232A1 Method for identifying an agent for treatment of niddmdiabetes by interaction with compound u0126
11/27/2002EP1259121A2 Weight loss induced by reduction in neuropeptide y level
11/27/2002EP1221954A4 Methods for identifying inhibitors of methionine aminopeptidases